Skip to main content

Table 3 Combined analysis of EGFR and KRAS status in NSCLC patients

From: Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

Primary/Metastatic tumor

 

WT/WT

WT/MUT

MUT/WT

MUT/MUT

Discordance

EGFR

54

5

0

21*

7 case

KRAS

73

6

0

1

6 case

  1. * E746-A750/L747-T751; L747-P753insS/R748-P752
  2. Abbreviation: WT, wild type; MUT, mutational type